Immunotherapies such as immune checkpoint blockade (ICB) and adoptive cell therapy
(ACT) have revolutionized cancer treatment, especially in patients whose disease was …

The immune system is the hard-wired host defense mechanism against pathogens as well
as cancer. Five years ago, we pondered the question if the era of cancer immunotherapy …

The results of recent clinical trials using novel immunotherapy strategies such as immune
checkpoint blockade and adoptive T-cell therapy approaches including CAR T-cell therapy …

Immune checkpoint blockade (ICB) has revolutionized cancer treatment. However,
resistance to ICB occurs frequently due to tumor-intrinsic alterations or extrinsic factors in the …

Simple Summary Immunotherapy helps a person's immune system to target tumor cells.
Recent advances in cancer immunotherapy, including immune checkpoint inhibition …

The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor
T cell therapies represent a turning point in cancer immunotherapy. These successes also …

Although cancer chemotherapy has historically been considered immune suppressive, it is
now accepted that certain chemotherapies can augment tumor immunity. The recent …

Recent success of immunotherapy strategies such as immune checkpoint blockade in
several malignancies has established the role of immunotherapy in the treatment of cancer …

The advent of novel immunotherapies in the treatment of cancers has dramatically changed
the landscape of the oncology field. Recent developments in checkpoint inhibition therapies …

In the past decades, our knowledge about the relationship between cancer and the immune
system has increased considerably. Recent years' success of cancer immunotherapy …